Sign In
Buy VRTX
$480.25
-5.14 (-1.06%)
At Close: Jul 13, 2026
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
07:01pm, Monday, 13'th Jul 2026
Vertex Pharmaceuticals (VRTX) reached $480.25 at the closing of the latest trading day, reflecting a -1.06% change compared to its last close.
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy?
02:27pm, Monday, 13'th Jul 2026
Vertex is buying Crinetics Pharmaceuticals for $10 billion. The acquisition could add up to $5 billion in revenue.
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
05:03pm, Saturday, 11'th Jul 2026
Vertex Pharmaceuticals NASDAQ: VRTX said it has entered into a definitive agreement to acquire Crinetics Pharmaceuticals for $85 per share in cash, a transaction Vertex executives described as a strat
Is This Biotech Stock a Buy Near Its 52-Week High?
05:00pm, Friday, 10'th Jul 2026
Vertex Pharmaceuticals is making clinical and regulatory progress with some promising candidates. The company's most important business is still performing well.
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy?
04:05am, Friday, 10'th Jul 2026
Vertex Pharmaceuticals is the global leader in cystic fibrosis treatments, and this has translated into billion-dollar earnings. The biotech has taken key steps in recent years to expand into other tr
Why Crinetics Stock Soared 99% This Week
01:29pm, Thursday, 09'th Jul 2026
Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this week, from $42.03 at Monday's close, to $83.54 earlier today.
Jim Cramer Says Biotech is The Hottest Group in The Market Right Now
11:35am, Thursday, 09'th Jul 2026
CNBC's Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter.
Nvidia, Vertex Pharmaceuticals And More On CNBC's ‘Final Trades'
07:45am, Thursday, 09'th Jul 2026
On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, named Roundhill Memory ETF (NASDAQ:DRAM) as her final trade.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of C
Vertex's Crinetics Deal Balances Growth with Integration Risk
09:05am, Wednesday, 08'th Jul 2026
Vertex Pharmaceuticals NASDAQ: VRTX recently announced its plans to acquire Crinetics Pharmaceuticals NASDAQ: CRNX for $10 billion. The deal, which has already been approved by the board of dir
Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.
03:28am, Wednesday, 08'th Jul 2026
Crinetics' Palsonify was FDA-approved late last year. The company's atumelnant is currently in late Phase 3 clinical testing.
Vertex Is Buying Crinetics for $10 Billion. Here's What Investors Need to Know.
11:00pm, Tuesday, 07'th Jul 2026
Vertex agreed to buy Crinetics for $85 per share in cash, about $10 billion in equity value. The deal adds a newly launched acromegaly drug and a late-stage candidate with more than $5 billion in comb
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
07:01pm, Tuesday, 07'th Jul 2026
Vertex Pharmaceuticals (VRTX) closed at $522.25 in the latest trading session, marking a -1.39% move from the prior day.
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
04:00pm, Tuesday, 07'th Jul 2026
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2026 financial results on Monday, August 3, 2026, after the financial markets close. The comp
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
12:30pm, Tuesday, 07'th Jul 2026
On CNBC's Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing that the sector could be entering a new wave of mergers and acquisitions as
